BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 15, 2017
View Archived Issues
Arcus Biosciences completes series C financing, begins two clinical trials
Read More
OX1 receptor antagonist C4X_3256 demonstrates efficacy in nicotine dependence rat model
Read More
Preclinical results for PF-3628, a new non-catechol D1 receptor agonist for schizophrenia
Read More
Clinical progress reported for Pfizer's IRAK-4 inhibitor PF-06650833
Read More
CRISPR Therapeutics, Casebia Therapeutics and CureVac form gene-editing program collaboration
Read More
EMA committee supports approval of Endoceutics' Intrarosa
Read More
FDA approves Allergan's sNDA for Vraylar
Read More
European Commission grants marketing authorization for self-injectable formulation of Benlysta
Read More
Bayer and Loxo Oncology collaborate to develop and commercialize highly selective TRK inhibitors
Read More
Certainty Therapeutics to develop CAR-T technology from Wistar Institute
Read More
Dosing begins in first-in-human phase Ib study of DEN-181
Read More
EC approves Faslodex in combination with palbociclib for HR+, HER2- breast cancer
Read More
EMA's CHMP issues positive opinion on Adcetris for CTCL
Read More
Phase II study of topical radezolid for acne begins
Read More
FDA approves Fasenra for severe eosinophilic asthma
Read More
EMA grants Motrem access to PRIME scheme for septic shock
Read More
Discovery of novel orally bioavailable CDK12 covalent inhibitors at Aurigene
Read More
Achillion reports preliminary data from phase II study of ACH-4471 in C3G
Read More
Boehringer Ingelheim's adalimumab biosimilar, Cyltezo, approved in E.U.
Read More
Novel IAP antagonists identified at Medshine Discovery
Read More
Everon Biosciences describes compounds to remove senescence-associated macrophages
Read More
BeiGene begins pivotal trials for BGB-3111
Read More
Astar Biotech divulges novel tyrosine kinase Bcr-Abl inhibitors
Read More
Monopar Therapeutics acquires phase II cancer drug candidate
Read More
The University of Texas discovers novel sigma1/2 receptor antagonists
Read More
New yohimbine analogues synthesized at the University of Florida
Read More
First commercial launch for Fotivda
Read More
Otsuka offers overview of third quarter 2017
Read More
First-in-human results provided for TR-Pharm's anti-interleukin-1 biologic RPH-104
Read More